Literature DB >> 21606146

Quality measures for the care of children with otitis media with effusion.

Carole Lannon1, Laura E Peterson, Anthony Goudie.   

Abstract

BACKGROUND: Current national efforts provide an opportunity to integrate performance measures into clinical practice and improve outcomes for children.
OBJECTIVE: The goal of this study was to explore issues in developing and testing measures of care for children with otitis media with effusion (OME).
METHODS: We assessed compliance with diagnostic, evaluation, and treatment measures for OME adapted from preliminary work of the Physician Consortium for Performance Improvement, using chart data in a convenience sample of practices from 2 primary care networks (Cincinnati Pediatric Research Group and the American Academy of Pediatrics Quality Improvement Innovation Network). Children aged 2 months to 12 years with at least 1 visit with a specified OME code during a 1-year period were included.
RESULTS: Of 23 practices, 4 could not locate eligible visits. Nineteen practices submitted 378 abstractions (range: 3-37 per practice) with 15 identifying <30 eligible visits. Performance on diagnosis (33%) and hearing evaluation (29%) measures was low but high on measures of appropriate medication use (97% decongestant/antihistamine, 87% antibiotics, and 95% corticosteroids). Thirty-five percent of records documented antibiotic use concurrent with OME; only 16% of the 94 cases that cited reason for prescribing were appropriate. Using methods that consider appropriate clinical action, a more accurate rate for appropriate use of antibiotics was 68%.
CONCLUSIONS: Coding, case finding, and evaluating appropriateness of treatment are some of the issues that will need to be considered to assess the care of children with OME. This study emphasizes the importance of testing proposed quality of care measures in "real-world" settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606146      PMCID: PMC3387874          DOI: 10.1542/peds.2009-3569

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

Review 1.  Emerging therapies for the treatment and prevention of otitis media.

Authors:  Avner Aliphas; Neil Prufer; Kenneth M Grundfast
Journal:  Expert Opin Emerg Drugs       Date:  2006-05       Impact factor: 4.191

2.  2 x 2 kappa coefficients: measures of agreement or association.

Authors:  D A Bloch; H C Kraemer
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

3.  Improving acute otitis media outcomes through proper antibiotic use and adherence.

Authors:  Diana I Brixner
Journal:  Am J Manag Care       Date:  2005-08       Impact factor: 2.229

4.  Exclusion of patients from pay-for-performance targets by English physicians.

Authors:  Tim Doran; Catherine Fullwood; David Reeves; Hugh Gravelle; Martin Roland
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

5.  Diagnosis, natural history, and late effects of otitis media with effusion.

Authors:  P Shekelle; G Takata; L S Chan; R Mangione-Smith; P M Corley; T Morphew; S Morton
Journal:  Evid Rep Technol Assess (Summ)       Date:  2002-06

6.  Frequency of inappropriate medical exceptions to quality measures.

Authors:  Stephen D Persell; Nancy C Dolan; Elisha M Friesema; Jason A Thompson; Darren Kaiser; David W Baker
Journal:  Ann Intern Med       Date:  2010-02-16       Impact factor: 25.391

Review 7.  Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.

Authors:  Joseph P Lynch; George G Zhanel
Journal:  Semin Respir Crit Care Med       Date:  2005-12       Impact factor: 3.119

Review 8.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Clinical characteristics of New York City children who received tympanostomy tubes in 2002.

Authors:  Salomeh Keyhani; Lawrence C Kleinman; Michael Rothschild; Joseph M Bernstein; Rebecca Anderson; Melissa Simon; Mark Chassin
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

10.  Treatment of otitis media with observation and a safety-net antibiotic prescription.

Authors:  Robert M Siegel; Michele Kiely; James P Bien; Evelyn C Joseph; James B Davis; Sandra G Mendel; John P Pestian; Thomas G DeWitt
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

View more
  6 in total

1.  Use and teaching of pneumatic otoscopy in a family medicine residency program.

Authors:  Eva Ouedraogo; Michel Labrecque; Luc Côté; Katerine Charbonneau; France Légaré
Journal:  Can Fam Physician       Date:  2013-09       Impact factor: 3.275

2.  Initial findings of shortwave infrared otoscopy in a pediatric population.

Authors:  Tulio A Valdez; Jessica A Carr; Katherine R Kavanagh; Marissa Schwartz; Danielle Blake; Oliver Bruns; Moungi Bawendi
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2018-08-23       Impact factor: 1.675

Review 3.  Understanding Quality Measures in Otolaryngology-Head and Neck Surgery.

Authors:  Peter M Vila; John S Schneider; Jay F Piccirillo; Judith E C Lieu
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-01       Impact factor: 6.223

4.  Vitamin D Levels in Children with Adenotonsillar Hypertrophy and Otitis Media with Effusion.

Authors:  Alimohamad Asghari; Zohreh Bagheri; Maryam Jalessi; Mohammad Mahdi Salem; Elahe Amini; Sahand GhalehBaghi; Sepideh Bakhti
Journal:  Iran J Otorhinolaryngol       Date:  2017-01

5.  Variation in antibiotic use among and within different settings: a systematic review.

Authors:  Veronica Zanichelli; Annelie A Monnier; Inge C Gyssens; Niels Adriaenssens; Ann Versporten; Céline Pulcini; Marion Le Maréchal; Gianpiero Tebano; Vera Vlahovic-Palcevski; Mirjana Stanic Benic; Romina Milanic; Stephan Harbarth; Marlies E Hulscher; Benedikt Huttner
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

Review 6.  Otitis media.

Authors:  Anne G M Schilder; Tasnee Chonmaitree; Allan W Cripps; Richard M Rosenfeld; Margaretha L Casselbrant; Mark P Haggard; Roderick P Venekamp
Journal:  Nat Rev Dis Primers       Date:  2016-09-08       Impact factor: 52.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.